RespireRx Pharmaceuticals Inc (fka RSPI)

[atheroprevent]

Neuro, did you note any R+R participation or presence?

I was impressed that the RD trials started patients within 72 hours after regulatory approval (even if incentivized).

I also liked the fact that the Huntingtons Foundation was excited enough about the ampakine effect in the animal model, that they wanted to test further on their own dime. This could translate to a higher regard for our discounted shares and possibly to some non traditional funding down the road.